Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.

MLA

Woods, Conor P., et al. “Adrenal Suppression in Patients Taking Inhaled Glucocorticoids Is Highly Prevalent and Management Can Be Guided by Morning Cortisol.” European Journal of Endocrinology, vol. 173, no. 5, Nov. 2015, pp. 633–42. EBSCOhost, https://doi.org/10.1530/EJE-15-0608.

APA

Woods, C. P., Argese, N., Chapman, M., Boot, C., Webster, R., Dabhi, V., Grossman, A. B., Toogood, A. A., Arlt, W., Stewart, P. M., Crowley, R. K., & Tomlinson, J. W. (2015). Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. European Journal of Endocrinology, 173(5), 633–642. https://doi.org/10.1530/EJE-15-0608

Chicago

Woods, Conor P, Nicola Argese, Matthew Chapman, Christopher Boot, Rachel Webster, Vijay Dabhi, Ashley B Grossman, et al. 2015. “Adrenal Suppression in Patients Taking Inhaled Glucocorticoids Is Highly Prevalent and Management Can Be Guided by Morning Cortisol.” European Journal of Endocrinology 173 (5): 633–42. doi:10.1530/EJE-15-0608.